Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• Niravath et al. (2019): Randomized controlled trial of high‐dose versus standard‐dose vitamin D3 for prevention of aromatase inhibitor‐induced arthralgia  + (n=2 not start treatment (withdrew consent); n=3 not complete 12 weeks (n=2 withdrew consent, n=1 non-compliant))
• Khan et al. (2017): Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial  + (n=2 protocol violations, n=7 withdrew for reasons other than study agent related adverse events)
• Niravath et al. (2019): Randomized controlled trial of high‐dose versus standard‐dose vitamin D3 for prevention of aromatase inhibitor‐induced arthralgia  + (n=4 not start treatment (n=3 withdrew consent, n=1 ineligible); n=1 not complete 12 weeks, found ineligible)

• Raoufinejad et al. (2019): Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a randomized clinical trial  + (n=4, death before day 30)

• Ribeiro et al. (2017): Effects of zinc supplementation on fatigue and quality of life in patients with colorectal cancer  + (n=9 chemotherapy was not indicated, n=1 refused chemotherapy)
• Urashima et al. (2019): Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers The AMATERASU Randomized Clinical Trial  + (stopped study medication (n=10 for nonmedical reasons, n=9 for medical reasons))